Adenocarcinoma News and Research

RSS
Adenocarcinoma is cancer that begins in cells that line certain internal organs and that have gland-like (secretory) properties.
Healthy dietary habits are important for GCA prevention

Healthy dietary habits are important for GCA prevention

New finding reveals Barrett's esophagus in asymptomatic women undergoing endoscopic screening

New finding reveals Barrett's esophagus in asymptomatic women undergoing endoscopic screening

FDA acknowledges Dendreon's amended BLA for PROVENGE as a complete response

FDA acknowledges Dendreon's amended BLA for PROVENGE as a complete response

Recent progress of Delcath Systems in drug delivery platform reported

Recent progress of Delcath Systems in drug delivery platform reported

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

YM BioSciences presents preclinical results of its small molecule VDA at the AACR-NCI-EORTC conference

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

New HPV vaccine eliminates chronic infection and reduces precancerous genital lesions in women

Dendreon submits an amended BLA for PROVENGE active cellular immunotherapy

Dendreon submits an amended BLA for PROVENGE active cellular immunotherapy

New diagnostic test for detecting colorectal cancer

New diagnostic test for detecting colorectal cancer

Genetic susceptibility study for Barrett's esophagus and esophageal adenocarcinoma awarded $7.9M grant

Genetic susceptibility study for Barrett's esophagus and esophageal adenocarcinoma awarded $7.9M grant

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

TomoTherapy radiation therapy platform to be presented at the ASTRO Annual Meeting

Rosetta Genomics, GTG sign exclusive distribution agreement

Rosetta Genomics, GTG sign exclusive distribution agreement

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

GlaxoSmithKline receives FDA approval for cervical cancer vaccine

Prometheus Laboratories introduces three new cancer diagnostic products

Prometheus Laboratories introduces three new cancer diagnostic products

NIH grants over $3.8 million to Asuragen

NIH grants over $3.8 million to Asuragen

New molecular imaging technique raises hope for common malignant female tumor

New molecular imaging technique raises hope for common malignant female tumor

Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancer

Promising results from Cell Therapeutics' phase II OPAXIO study for advanced esophageal cancer

Memorial Sloan-Kettering Cancer Center awards $50,000 to three young investigators

Memorial Sloan-Kettering Cancer Center awards $50,000 to three young investigators

Winners of Paul Marks Prize 2009

Winners of Paul Marks Prize 2009

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Pfizer to commence Phase 3 trial of oral c-Met and ALK inhibitor

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

Study reveals that patients with NSCLC who received maintenance therapy with ALIMTA showed survival benefit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.